Trials / Sponsors / Anhui Shi, MD
Anhui Shi, MD
Academic / Other · 4 registered clinical trials — 1 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Durvalumab After Concurrent Chemoradiotherapy (cCRT) for Limited-stage Small-cell Lung Cancer (LS-SCLC) Small-cell Lung Cancer | — | 2025-08-11 |
| Not Yet Recruiting | Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001) Extensive-stage Small Cell Lung Cancer | Phase 3 | 2024-12-16 |
| Completed | Anlotinib After Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer（ALTER-L029） Non-Small Cell Lung Cancer Stage III | Phase 2 | 2019-04-12 |
| Completed | Twice-daily SIB Radiotherapy Versus Standard Radiotherapy for Patients With SCLC Small Cell Lung Cancer Limited Stage, Radiotherapy | N/A | 2017-06-30 |